Skip to main content

A Phase 1b, Randomized, Blinded, Dose-Determined Study Evaluating the Safety and Tolerability of Intervention with AT-100 (rhSP-D) in Preterm Neonates at High Risk for the Development of Bronchopulmonary Dysplasia (BPD)

Clinical Trial Grant
Duke Scholars

Administered By

Pediatrics, Neonatology

Awarded By

Airway Therapeutics

Start Date

October 27, 2021

End Date

September 30, 2024
 

Administered By

Pediatrics, Neonatology

Awarded By

Airway Therapeutics

Start Date

October 27, 2021

End Date

September 30, 2024